Roche buys Adheron
A research-based healthcare company, Roche, has bought Adheron Therapeutics
Pharmaceuticals, Biotechnology and Life Sciences
A research-based healthcare company, Roche, has bought Adheron Therapeutics
National Institutes of Health (NIH) has launched a new phase of the Breast Cancer and the Environment Research Program (BCERP), focused on prevention.
U.S. Food & Drug Administration (FDA) has updated information on Drug Shortages.
Verona Pharma plc, a London-listed drug development company focused on medicines to treat respiratory diseases, has appointed new Non-Executive Directors of the Company
Novartis has announced a new analysis from the phase III FREEDOMS and FREEDOMS II trials reinforcing the long-term efficacy profile of Gilenya (fingolimod).
Sanofi and its subsidiary Genzyme announced positive new five-year investigational data from the extension study of Lemtrada (alemtuzumab) for patients with relapsing remitting multiple sclerosis (RRMS).
Watch a video and take a look at the U.S. government’s response in addressing Ebola in the United States.